D. Kocer Et Al. , "Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-beta 1 in Autosomal Dominant Polycystic Kidney Disease Patients," THERAPEUTIC APHERESIS AND DIALYSIS , vol.20, no.5, pp.517-522, 2016
Kocer, D. Et Al. 2016. Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-beta 1 in Autosomal Dominant Polycystic Kidney Disease Patients. THERAPEUTIC APHERESIS AND DIALYSIS , vol.20, no.5 , 517-522.
Kocer, D., Karakukcu, C., Ozturk, F., EROĞLU, E., & KOÇYİĞİT, I., (2016). Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-beta 1 in Autosomal Dominant Polycystic Kidney Disease Patients. THERAPEUTIC APHERESIS AND DIALYSIS , vol.20, no.5, 517-522.
Kocer, Derya Et Al. "Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-beta 1 in Autosomal Dominant Polycystic Kidney Disease Patients," THERAPEUTIC APHERESIS AND DIALYSIS , vol.20, no.5, 517-522, 2016
Kocer, Derya Et Al. "Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-beta 1 in Autosomal Dominant Polycystic Kidney Disease Patients." THERAPEUTIC APHERESIS AND DIALYSIS , vol.20, no.5, pp.517-522, 2016
Kocer, D. Et Al. (2016) . "Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-beta 1 in Autosomal Dominant Polycystic Kidney Disease Patients." THERAPEUTIC APHERESIS AND DIALYSIS , vol.20, no.5, pp.517-522.
@article{article, author={Derya KOÇER Et Al. }, title={Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-beta 1 in Autosomal Dominant Polycystic Kidney Disease Patients}, journal={THERAPEUTIC APHERESIS AND DIALYSIS}, year=2016, pages={517-522} }